Main Article Content
The aim was to study the protective effect of ethanolic extract of Achillea millefolium on acute vascular injuries induced by cisplatin in liver, heart and renal tissues 24 hour after administration and using histopathological surveys in wistar rats. 24 adult male wistar rats were randomly divided into four groups. Group I (control group) received physiological saline for 10 days. Animals of group II had single dose of injection of CP (cisplatin) (6 mg/kg, IP) on the ninth day. Group III received Achillea millefolium extract (250 mg/kg, gavage) for 10 consecutive days. Group IV had both Achillea millefolium extract (250 mg/kg, gavage) for 10 consecutive days and a single dose of injection of CP (6 mg/kg, IP) on the ninth day. Kidney, liver and heart organs were collected on 10th day from sacrificed rats and subjected to histopathological analysis. Then the possible histopathological vascular effects of cisplatin on liver, heart, kidney tissues and the protective effect of Achillea millefolium extract was analysed. Obtained data showed the vascular injuries in CP group as congestion of cardiac capillaries (p=0.00) and interstitial edema (p=0.03). In the kidney, shrinkage of glomeruli (p=0.04), widening of Bowman's space (p=0.04), dilatation of cortical capillaries (p=0.01) were significantly altered. The findings of liver organ were increased sinusoidal space (p=0.00) and infiltration of neutrophils in portal space (p=0.01). Pretreatment with ethanolic extract of Achillea millefolium could attenuate these vascular injuries. Briefly, 24 hour after single injection of cisplatin the inflammatory process was seen in vital organs and administration of Achillea millefolium could mitigate these side effects.
Manohar S, Leung N. Cisplatin nephrotoxicity: A review of the literature. Journal of Nephrology. 2018;31(1):15-25.
Tixier F, Ranchon F, Iltis A, Vantard N, Schwiertz V, Bachy E, et al. Comparative toxicities of 3 platinum‐containing chemotherapy regimens in relapsed/refractory lymphoma patients. Hematological Oncology. 2017;35(4):584-90.
Amable L. Cisplatin resistance and opportunities for precision medicine. Pharmacological Research. 2016;106:27-36.
Ozkok A, Edelstein CL. Pathophysiology of cisplatin-induced acute kidney injury. BioMed Research International; 2014.
Pasetto LM, D’Andrea MR, Brandes AA, Rossi E, Monfardini S. The development of platinum compounds and their possible combination. Critical Reviews in Oncology/ Hematology. 2006;60(1):59-75.
Beyer J, Rick O, Weinknecht S, Kingreen D, Lenz K, Siegert W. Nephrotoxicity after high-dose carboplatin, etoposide and ifosfamide in germ-cell tumors: Incidence and implications for hematologic recovery and clinical outcome. Bone marrow transplantation. 1997;20(10):813.
Arany I, Safirstein RL, editors. Cisplatin nephrotoxicity. Seminars in nephrology; Elsevier; 2003.
Palipoch S, Punsawad C. Biochemical and histological study of rat liver and kidney injury induced by cisplatin. Journal of Toxicologic Pathology. 2013;26(3):293-9.
Ekor M, Emerole GO, Farombi EO. Phenolic extract of soybean (Glycine max) attenuates cisplatin-induced nephrotoxicity in rats. Food and Chemical Toxicology. 2010;48(4):1005-12.
El-Beshbishy HA, Bahashwan SA, Aly HA, Fakher HA. Abrogation of cisplatin-induced nephrotoxicity in mice by alpha lipoic acid through ameliorating oxidative stress and enhancing gene expression of antioxidant enzymes. European Journal of Pharmacology. 2011;668(1-2):278-84.
An Y, Xin H, Yan W, Zhou X. Amelioration of cisplatin-induced nephrotoxicity by pravastatin in mice. Experimental and Toxicologic Pathology. 2011;63(3):215-9.
Koc A, Duru M, Ciralik H, Akcan R, Sogut S. Protective agent, erdosteine, against cisplatin-induced hepatic oxidant injury in rats. Molecular and Cellular Biochemistry. 2005;278(1-2):79-84.
Mansour HH, Hafez HF, Fahmy NM. Silymarin modulates cisplatin-induced oxidative stress and hepatotoxicity in rats. Journal of Biochemistry and Molecular Biology. 2006;39(6):656.
Pollera C, Ameglio F, Nardi M, Vitelli G, Marolla P. Cisplatin-induced hepatic toxicity. Journal of Clinical Oncology. 1987; 5(2):318-9.
El-Awady E-SE, Moustafa YM, Abo-Elmatty DM, Radwan A. Cisplatin-induced cardiotoxicity: Mechanisms and cardioprotective strategies. European Journal of Pharmacology. 2011;650(1): 335-41.
Eschenhagen T, Force T, Ewer MS, De Keulenaer GW, Suter TM, Anker SD, et al. Cardiovascular side effects of cancer therapies: A position statement from the Heart Failure Association of the European Society of Cardiology. European Journal of Heart Failure. 2011;13(1):1-10.
Wang D, Lippard SJ. Cellular processing of platinum anticancer drugs. Nature Reviews Drug Discovery. 2005;4(4):307.
Shahraki Salar M, Arab M, Arab MR, Mashhadi MA, Sargolzaei Aval F, Mir M, et al. Cisplatin Induce Urinary Space Obstruction and Tubular Necrosis in Rat Kidney. Anatomical Sciences Journal. 2016;13(3):191-6.
Miller R, Tadagavadi R, Ramesh G, Reeves W. Mechanisms of Cisplatin nephrotoxicity. Toxins. 2010;2(11):2490-2518.
Cui Y, Li C, Zeng C, Li J, Zhu Z, Chen W, et al. Tongmai Yangxin pills anti-oxidative stress alleviates cisplatin-induced cardiotoxicity: network pharmacology analysis and experimental evidence. Biomedicine & Pharmacotherapy. 2018; 108:1081-9.
Dugbartey GJ, Peppone LJ, de Graaf IA. An integrative view of cisplatin-induced renal and cardiac toxicities: Molecular mechanisms, current treatment challenges and potential protective measures. Toxicology. 2016;371:58-66.
Zhang P, Yi LH, Meng GY, Zhang HY, Sun HH, Cui LQ. Apelin-13 attenuates cisplatin-induced cardiotoxicity through inhibition of ROS-mediated DNA damage and regulation of MAPKs and AKT pathways. Free Radical Research. 2017;51(5):449-59.
Radušiene J, Gudaityte O. Distribution of proazulenes in Achillea millefolium sl wild populations in relation to phytosociological dependence and morphological characters. Plant genetic resources. 2005; 3(2):136-43.
Dias MI, Barros L, Dueñas M, Pereira E, Carvalho AM, Alves RC, et al. Chemical composition of wild and commercial Achillea millefolium L. and bioactivity of the methanolic extract, infusion and decoction. Food Chemistry. 2013;141(4):4152-60.
Ali SI, Gopalakrishnan B, Venkatesalu V. Pharmacognosy, phytochemistry and pharmacological properties of Achillea millefolium L.: A review. Phytotherapy Research. 2017;31(8):1140-61.
Sevindik HG, Güvenalp Z, Yerdelen KÖ, Yuca H, Demirezer LÖ. The discovery of potential anticholinesterase compounds from Achillea millefolium L. Industrial Crops and Products. 2015;76:873-9.
Jenabi E, Fereidoony B. Effect of achillea millefolium on relief of primary dysmenorrhea: A double-blind randomized clinical trial. Journal of Pediatric and Adolescent Gynecology. 2015;28(5):402-4.
Benedek B, Geisz N, Jäger W, Thalhammer T, Kopp B. Choleretic effects of yarrow (Achillea millefolium sl) in the isolated perfused rat liver. Phytomedicine. 2006;13(9-10):702-6.
Villalva M, Jaime L, Villanueva-Bermejo D, Lara B, Fornari T, Reglero G, et al. Supercritical anti-solvent fractionation for improving antioxidant and anti-inflammatory activities of an Achillea millefolium L. extract. Food Research International. 2019;115:128-34.
Shah R, Peethambaran B. Anti-inflammatory and Anti-microbial Properties of Achillea millefolium in Acne Treatment. Immunity and Inflammation in Health and Disease: Elsevier. 2018;241-8.
Pereira JM, Peixoto V, Teixeira A, Sousa D, Barros L, Ferreira IC, et al. Achillea millefolium L. hydroethanolic extract has phenolic compounds and inhibits the growth of human tumor cell lines. Free Radical Biology and Medicine. 2018;120: S145.
ANTUNES LMG, DARIN JDAC, BIANCHI MDLP. Protective effects of vitamin C against cisplatin-induced nephrotoxicity and lipid peroxidation in adult rats: A dose-dependent study. Pharmacological Research. 2000;41(4):405-11.
Ojha S, Venkataraman B, Kurdi A, Mahgoub E, Sadek B, Rajesh M. Plant-derived agents for counteracting cisplatin-induced nephrotoxicity. Oxidative medicine and cellular longevity. 2016;2016.
Zhang JG, Viale M, Esposito M, Lindup W. Tiopronin protects against the nephrotoxicity of cisplatin in the rat. Human & Experimental Toxicology. 1999;18(12): 713-7.
Karwasra R, Kalra P, Gupta YK, Saini D, Kumar A, Singh S. Antioxidant and anti-inflammatory potential of pomegranate rind extract to ameliorate cisplatin-induced acute kidney injury. Food & Function. 2016;7(7):3091-101.
Mustafa KG, Ganai BA, Akbar S, Dar MY, Masood A. β-Cell protective efficacy, hypoglycemic and hypolipidemic effects of extracts of Achillea millifolium in diabetic rats. Chinese Journal of Natural Medicines. 2012;10(3):185-9.
Cisplatin Eoveo, Light A. Amel MM Abdel-Hafez. AAMJ. 2004;2(3).
Galanski M, Arion V, Jakupec M, Keppler B. Recent developments in the field of tumor-inhibiting metal complexes. Current Pharmaceutical Design. 2003;9(25):2078-89.
Oun R, Moussa YE, Wheate NJ. The side effects of platinum-based chemotherapy drugs: A review for chemists. Dalton Transactions. 2018;47 (19):6645-53.
Hosseinian S, Rad AK, Mousa-Al-Reza Hadjzadeh NM, Roshan SH, Shafiee S. The protective effect of Nigella sativa against cisplatin-induced nephrotoxicity in rats. Avicenna Journal of Phytomedicine. 2016;6(1):44.
Sharma S, Joshi A, Hemalatha S. Protective effect of Withania coagulans fruit extract on cisplatin-induced nephrotoxicity in rats. Pharmacognosy Research. 2017;9(4):354.
Hosseinian S, Hadjzadeh MAR, Roshan NM, Khazaei M, Shahraki S, Mohebbati R, et al. Renoprotective effect of Nigella sativa against cisplatin-induced nephrotoxicity and oxidative stress in rat. Saudi Journal of Kidney Diseases and Transplantation: An official publication of the Saudi Center for Organ Transplantation, Saudi Arabia. 2018;29(1): 19-29.
Kim ES, Lee JS, Akram M, Kim KA, Shin YJ, Yu JH, et al. Protective activity of Dendropanax morbifera against cisplatin-induced acute kidney injury. Kidney and Blood Pressure Research. 2015;40(1):1-12.
Rjiba-Touati K, Ayed-Boussema I, Belarbia A, Azzebi A, Achour A, Bacha H. Protective effect of recombinant human erythropoeitin against cisplatin cytotoxicity and genotoxicity in cultured Vero cells. Experimental and Toxicologic Pathology. 2013;65(1-2):181-7.
Sestili P, Diamantini G, Bedini A, Cerioni L, Tommasini I, Tarzia G, et al. Plant-derived phenolic compounds prevent the DNA single-strand breakage and cytotoxicity induced by tert-butylhydroperoxide via an iron-chelating mechanism. Biochemical Journal. 2002;364(1):121-8.
Serdar G, Sökmen M, Demir E, Sökmen A, Bektaş E. Extraction of antioxidative principles of Achillea biserrata M. Bieb. and chromatographic analyses. International Journal of Secondary Metabolite. 2015;2(2):3-15.
Benedec D, Oniga I, Muresan B, Mot AC, Damian G, Nistor A, et al. Contrast between water‐and ethanol‐based antioxidant assays: Aspen (Populus tremula) and black poplar (Populus nigra) extracts as a case study. Journal of Food Quality. 2014;37(4):259-67.
Tozyo T, Yoshimura Y, Sakurai K, Uchida N, Takeda Y, Nakai H, et al. Novel antitumor sesquiterpenoids in Achillea millefolium. Chemical and pharmaceutical bulletin. 1994;42(5):1096-100.
Benedek B, Kopp B, Melzig MF. Achillea millefolium L. sl–Is the anti-inflammatory activity mediated by protease inhibition? Journal of Ethnopharmacology. 2007;113 (2):312-7.
Alhoshani AR, Hafez MM, Husain S, Al-sheikh AM, Alotaibi MR, Al Rejaie SS, et al. Protective effect of rutin supplementation against cisplatin-induced Nephrotoxicity in rats. BMC Nephrology. 2017;18(1):194.
Yao X, Panichpisal K, Kurtzman N, Nugent K. Cisplatin nephrotoxicity: A review. The American Journal of the Medical Sciences. 2007;334(2):115-24.
Dasari S, Tchounwou PB. Cisplatin in cancer therapy: Molecular mechanisms of action. European Journal of Pharmacology. 2014;740:364-78.
Sánchez-González PD, López-Hernández FJ, López-Novoa JM, Morales AI. An integrative view of the pathophysiological events leading to cisplatin nephrotoxicity. Critical Reviews in Toxicology. 2011;41 (10):803-21.
Miller RP, Tadagavadi RK, Ramesh G, Reeves WB. Mechanisms of cisplatin nephrotoxicity. Toxins. 2010;2(11):2490-518.
Filipski KK, Mathijssen RH, Mikkelsen TS, Schinkel AH, Sparreboom A. Contribution of organic cation transporter 2 (OCT2) to cisplatin‐induced nephrotoxicity. Clinical Pharmacology & Therapeutics. 2009;86 (4):396-402.
Moreno-Gordaliza E, Giesen C, Lázaro A, Esteban-Fernández D, Humanes B, Canas B, et al. Elemental bioimaging in kidney by LA–ICP–MS as a tool to study nephrotoxicity and renal protective strategies in cisplatin therapies. Analytical Chemistry. 2011;83(20):7933-40.
Amin RP, Vickers AE, Sistare F, Thompson KL, Roman RJ, Lawton M, et al. Identification of putative gene based markers of renal toxicity. Environmental Health Perspectives. 2004;112(4):465-79.
Akcay A, Nguyen Q, He Z, Turkmen K, Lee DW, Hernando AA, et al. IL-33 exacerbates acute kidney injury. Journal of the American Society of Nephrology. 2011;22(11):2057-67.
Cure E, Kirbas A, Tumkaya L, Cure MC, Şahin OZ, Kalkan Y, et al. Effect of infliximab against cisplatin-induced nephrotoxicity. Saudi Medical Journal. 2014;35(9):953.
Tarladacalisir YT, Kanter M, Uygun M. Protective effects of vitamin C on cisplatin-induced renal damage: a light and electron microscopic study. Renal Failure. 2008;30 (1):1-8.
MM Z. Hematoprotective and nephroprotective effects of Achillea millefolium aqueous extract in diabetic mice. Res J Pharmacogn. 2018;5(3): 57-68.
Bafrani HH, Parsa Y, Yadollah-Damavandi S, Jangholi E, Ashkani-Esfahani S, Gharehbeglou M. Biochemical and pathological study of hydroalcoholic extract of Achillea millefolium l. on ethylene glycol-induced nephrolithiasis in laboratory rats. North American Journal of Medical Sciences. 2014;6(12):638.
Vahid S, Dashti-Khavidaki S, Ahmadi F, Amini M, Surmaghi MHS. Effect of herbal medicine Achillea millefolium on plasma nitrite and nitrate levels in patients with chronic kidney disease: A preliminary study. Iranian Journal of Kidney Diseases. 2012;6(5):350.
Topal İ, Bilgin AÖ, Çimen FK, Kurt N, Süleyman Z, Bilgin Y, et al. The effect of rutin on cisplatin-induced oxidative cardiac damage in rats. Anatolian Journal of Cardiology. 2018;20(3):136.
Adalı F, Gonul Y, Kocak A, Yuksel Y, Ozkececi G, Ozdemir C, et al. Effects of thymoquinone against cisplatin-induced cardiac injury in rats. Acta cirurgica brasileira. 2016;31(4):271-7.
Bano N, Najam R, Qazi F. Adverse cardiac manifestations of cisplatin: A review. Int J Pharm Sci Rev Res. 2013;18(1):80-5.
Patanè S. Cardiotoxicity: Cisplatin and long-term cancer survivors. International Journal of Cardiology. 2014;175(1):201-2.
Mahmoudabady M, Lashkari M, Niazmand S, Soukhtanloo M. Cardioprotective effects of Achillea wilhelmsii on the isolated rat heart in ischemia–reperfusion. Journal of Traditional and Complementary Medicine. 2017;7(4):501-7.
Choti MA. Chemotherapy-associated hepatotoxicity: Do we need to be concerned? Annals of Surgical Oncology. 2009;16(9):2391-4.
Ghabril M, Vuppalanchi R, editors. Drug-induced nodular regenerative hyperplasia. Seminars in liver disease: Thieme Medical Publishers; 2014.
Chun YS, Laurent A, Maru D, Vauthey J-N. Management of chemotherapy-associated hepatotoxicity in colorectal liver metastases. The Lancet Oncology. 2009; 10(3):278-86.
Dadkhah A, Fatemi F, Ababzadeh S, Roshanaei K, Alipour M, Tabrizi BS. Potential preventive role of Iranian Achillea wilhelmsii C. Koch essential oils in acetaminophen-induced hepatotoxicity. Botanical Studies. 2014;55(1):37.
Abdel-Misih SR, Bloomston M. Liver anatomy. Surgical Clinics. 2010;90(4):643-53.
Robinson MW, Harmon C, O’Farrelly C. Liver immunology and its role in inflammation and homeostasis. Cellular & Molecular Immunology. 2016;13(3):267.